ArticlePloS one2025
Regenerating island-derived protein 3E concentrations in healthy dogs and dogs with various inflammatory processes.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serum pancreatitis-associated protein 1 concentrations in dogs with acute signs of gastrointestinal disease and normal or abnormal DGGR lipase activity.Journal of veterinary internal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlood concentrations of regenerating island-derived proteins (REG) are high in humans with sepsis, acute pancreatitis, and gastrointestinal diseases. REG3E was recently identified in canine pancreas and blood, but concentrations in dogs with various diseases are unknown.
objectivesTo measure and compare REG3E concentrations in dogs with sepsis, acute pancreatitis, gastrointestinal diseases, and healthy dogs.
methodsCross-sectional study measuring plasma REG3E concentrations using an in-house developed ELISA in stored convenience samples from client-owned dogs with naturally occurring sepsis (n = 44), acute pancreatitis (n = 42), acute (n = 25) and chronic gastrointestinal diseases (n = 23), and healthy controls (n = 80). Concentrations of REG3E are compared among groups and between survivors and non-survivors to discharge using the Kruskal-Wallis test with post-hoc Conover analysis and independent samples t-tests.
resultsREG3E concentrations differed significantly among all groups (P < 0.005), except between sepsis and acute pancreatitis (P = 0.936). Median concentrations (interquartile range [ng/mL]) were 36.5 (30-89) in healthy dogs, 200 (103.5-361.5) in dogs with chronic gastrointestinal diseases, 634 (257-1060) in dogs with acute gastrointestinal diseases, 1644.5 (710 - 4122) in dogs with acute pancreatitis, and 1736 (480.5-3416) in septic dogs. Non-survivors (n = 33) had significantly higher REG3E concentrations than survivors when compared across all clinically ill dogs (P < 0.001) and within the sepsis group (n = 20; P = 0.0133), but not within the acute pancreatitis group (n = 13; P = 0.248). CONCLUSIONS AND CLINICAL IMPORTANCE: Plasma REG3E concentrations are higher in dogs of all disease categories, particularly in dogs with sepsis and acute pancreatitis, but with considerable overlap between different diseases. High REG3E concentrations may be associated with poor prognosis in septic dogs. Thus, REG3E is likely to reflect inflammation and merits further investigations to refine its potential as a diagnostic and decision-making biomarker in this species.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.